| Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial | |
| Xiao, Shifu; Wang, Tao; Ma, Xiuqiang; Qin, Yingyi; Li, Xia; Zhao, Zhongxin; Liu, Xueyuan; Wang, Xiaoping; Xie, Hengge; Jiang, Qinpu | |
| 刊名 | AGE AND AGEING
 |
| 2017 | |
| 卷号 | 46期号:5 |
| 关键词 | older people octohydroaminoacridine Alzheimer's disease treatment novel drug Phase II trial |
| ISSN号 | 0002-0729 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3424214 |
| 专题 | 昆明医科大学 |
| 推荐引用方式 GB/T 7714 | Xiao, Shifu,Wang, Tao,Ma, Xiuqiang,et al. Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial[J]. AGE AND AGEING,2017,46(5). |
| APA | Xiao, Shifu.,Wang, Tao.,Ma, Xiuqiang.,Qin, Yingyi.,Li, Xia.,...&He, Jia.(2017).Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial.AGE AND AGEING,46(5). |
| MLA | Xiao, Shifu,et al."Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial".AGE AND AGEING 46.5(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论